Edited by L aszl o NagyMacrophages are innate immune cells that play a role not only in host defense against infections, but also in the pathophysiology of autoimmune and autoinflammatory disorders, as well as cancer. An important feature of macrophages is their high plasticity, with high ability to adapt to environmental changes by adjusting their cellular metabolism and immunological phenotype. Macrophages are one of the most abundant innate immune cells within the tumor microenvironment that have been associated with tumor growth, metastasis, angiogenesis and poor prognosis. In the context of cancer, however, so far little is known about metabolic changes in macrophages, which have been shown to determine functional fate of the cells in other diseases. Here, we review the current knowledge regarding the cellular metabolism of tumor-associated macrophages (TAMs) and discuss its implications for cell function. Understanding the regulation of the cellular metabolism of TAMs may reveal novel therapeutic targets for treatment of malignancies.Keywords: fatty acid; glycolysis; immunometabolism; oxidative phosphorylation; tumor-associated macrophage Abbreviations 2DG, 2-deoxyglucose; 5-LOX, 5-lipoxygenase; ACC, acetyl CoA carboxylase; AcCoA, acetyl coenzyme A; ACLY, ATP citrate lyase; AMPK, AMP-activated protein kinase; ANGPTL4, angiopoietin-like 4; ARG1, arginase 1; BMDMs, bone-marrow-derived macrophages; CARKL, sedoheptulokinase; COX, cyclooxygenase; CPT1, carnitine palmitoyl transferases I; E-FABP, epidermal fatty acid binding protein; ENO1, enolase 1; ETC, electron transfer chain; FA, fatty acid; FADH 2 , flavin adenine dinucleotide; FAO, fatty acid oxidation; FASN, fatty acid synthase; G6P, glucose-6-phosphate; Glu1, glutamine synthetase; HDAC, histone acetyl deacetylase; HIF1a, hypoxia-inducible factor 1-alpha; HK2, hexokinase-2; HO-1, hemeoxygenase; IDO, indoleamine-2,3-dioxygenase; IFN-c, interferon-c; IL, interleukin; iNOS, inducible nitric oxide synthase; LAL, lysosomal acid lipase; LCN, lipocalin; LDL, low-density lipoprotein; LLC, Lewis lung carcinoma; LPL, lipoprotein lipase; LPS, lipopolysaccharides; LRP5, LDL receptor-related protein; MAPK8, mitogen-activated protein kinase 8; MDSCs, myeloid-derived suppressor cells; MMP, matrix metalloproteinase; mTOR, mechanistic target of rapamycin; NAD, nicotinamide adenine dinucleotide; NO, nitric oxide; ODC, ornithine decarboxylase; oxLDL, oxidized LDL; OXPHOS, oxidative phosphorylation; PDK4, pyruvate dehydrogenase kinase 4; PFKFB1, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1; PFKFB3, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3; PGE 2 , prostaglandin E2; PI3K, phosphoinositide 3-kinase; PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PKM2, pyruvate kinase 2; PLIN2, perilipin-2; PPAR, peroxisome proliferator-activated receptor; PPP, pentose phosphate pathway; RCC, renal cell carcinoma; REDD1, regulated in development and DNA damage response 1; ROS, reactive oxygen species; SDH, succinate dehydrogenase; SREBP1c, sterol regulatory element bind...